Kinetics of antibody response to Ehrlichia canis immunoreactive proteins

Jere W McBride1, Richard E Corstvet, Steven D Gaunt

  • 1Department of Pathology, Sealy Center for Vaccine Development, and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA. jemcbride@utmb.edu

Infection and Immunity
|April 22, 2003
PubMed

Insights

This study tracked antibody responses in dogs infected with Ehrlichia canis, identifying key proteins like p28, gp140, and gp200 that elicit immune reactions. Early recognition of certain antigens suggests their importance in canine ehrlichiosis diagnosis and vaccines.

Area of Science:

  • Veterinary Immunology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Ehrlichia canis causes canine ehrlichiosis, a significant tick-borne disease.
  • Key immunoreactive proteins, including p28, gp140, and gp200, are known targets in canine ehrlichiosis.
  • The kinetics of antibody response to these antigens are not well understood.

Purpose of the Study:

  • To investigate the antibody response kinetics to Ehrlichia canis antigens in experimentally infected dogs.
  • To identify immunodominant E. canis antigens recognized during acute and convalescent infection phases.
  • To evaluate the potential of recombinant proteins (p28, gp140, gp200) as diagnostic or vaccine candidates.

Main Methods:

  • Experimental infection of dogs with E. canis.
  • Monitoring of acute-phase serum antibody responses over six weeks.
  • Analysis of antibody response to whole-cell lysates and recombinant proteins (p28, gp140, gp200).
  • Identification of major immunoreactive antigens based on intensity and quantity.

Main Results:

  • A T-helper 1-type immune response, characterized by IgG2 antibodies, was observed in most dogs.
  • Early infection recognized 19-, 37-, 75-, and 140-kDa proteins as major antigens.
  • Later infection identified 28-, 47-, 95-kDa proteins and the 200-kDa glycoprotein.
  • All dogs developed antibodies against recombinant gp140, gp200, and p28 by the convalescent phase.

Conclusions:

  • The study elucidates the antibody response kinetics to E. canis antigens in dogs.
  • Identified major immunoreactive proteins are immunodominant, with some antigens showing early dominance.
  • Recombinant p28, gp140, and gp200 are promising candidates for immunodiagnostics and vaccines against canine ehrlichiosis.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...